Barclays’s Ingevity NGVT Stock Holding History
Bought
Maintained
Sold
Other funds holding NGVT
SBH
RA
Barclays's NGVT Position: Q2 2026 in Review
Barclays reduced its Ingevity (NGVT) stake by 11% in Q2 2026, selling an estimated $74.7K and leaving 8,186 shares worth $611K. The position accounts for ﹤0.01% of the portfolio, ranked #3103.
Barclays first reported a position in NGVT in Q2 2016 and has held it in 41 quarters since. The position peaked at $6.54M in Q3 2018. 315 funds tracked by Wall St. Rank hold NGVT as of Q2 2026.
- Barclays held 8,186 shares of Ingevity worth $611K as of Q2 2026.
- Barclays sold 1,038 Ingevity shares in Q2 2026, an estimated $74.7K.
- Ingevity made up ﹤0.01% of Barclays's portfolio in Q2 2026, its #3103 holding.
- Barclays first reported a position in Ingevity in Q2 2016 and has held it in 41 quarters since.
- Barclays's Ingevity position peaked at $6.54M in Q3 2018.
- 315 funds tracked by Wall St. Rank held Ingevity as of Q2 2026.
Based on Barclays's 13F filing for Q2 2026, filed 14 Aug 2026.